254 related articles for article (PubMed ID: 3117249)
1. Impotence: treatment by autoinjection of vasoactive drugs.
Williams G; Mulcahy MJ; Kiely EA
Br Med J (Clin Res Ed); 1987 Sep; 295(6598):595-6. PubMed ID: 3117249
[TBL] [Abstract][Full Text] [Related]
2. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
Vardi Y; Lidgi S; Moskovitz B; Levin RD
Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
[TBL] [Abstract][Full Text] [Related]
3. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
[TBL] [Abstract][Full Text] [Related]
4. The use of vasoactive agents in the treatment of erectile impotence.
Fried FA
N C Med J; 1990 Jun; 51(6):295-6. PubMed ID: 2366889
[No Abstract] [Full Text] [Related]
5. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
Sidi AA; Cameron JS; Duffy LM; Lange PH
J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
[TBL] [Abstract][Full Text] [Related]
6. [Action of vasoactive drugs in male sexual impotence].
Morales JC; Elizondo B
Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
[TBL] [Abstract][Full Text] [Related]
7. [Intracavernous pharmacotherapy for organic impotence in the elderly].
Richter S; Shalev M; Nissenkorn I
Harefuah; 1990 Aug; 119(3-4):66-7. PubMed ID: 2227669
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
JAMA; 1990 Aug; 264(6):752-4. PubMed ID: 2374280
[No Abstract] [Full Text] [Related]
9. Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents.
Kiely EA; Bloom SR; Williams G
Br J Urol; 1989 Aug; 64(2):191-4. PubMed ID: 2765789
[TBL] [Abstract][Full Text] [Related]
10. Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients.
Girdley FM; Bruskewitz RC; Feyzi J; Graversen PH; Gasser TC
J Urol; 1988 Nov; 140(5):972-4. PubMed ID: 3172370
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic roles of intracavernosal papaverine.
Goldstein I; Payton T; Padma-Nathan H
Cardiovasc Intervent Radiol; 1988 Aug; 11(4):237-9. PubMed ID: 3147138
[TBL] [Abstract][Full Text] [Related]
12. Intracavernous injections for impotence.
Med Lett Drugs Ther; 1987 Oct; 29(751):95-6. PubMed ID: 3670212
[No Abstract] [Full Text] [Related]
13. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury.
Bodner DR; Lindan R; Leffler E; Kursh ED; Resnick MI
J Urol; 1987 Aug; 138(2):310-1. PubMed ID: 3599245
[TBL] [Abstract][Full Text] [Related]
14. [Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances].
Ferrière JM; Gaston R; Piechaud T; Le Guillou M
Ann Urol (Paris); 1988; 22(1):57-9. PubMed ID: 3369847
[TBL] [Abstract][Full Text] [Related]
15. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
Padma-Nathan H; Goldstein I; Krane RJ
Semin Urol; 1986 Nov; 4(4):236-8. PubMed ID: 3797893
[No Abstract] [Full Text] [Related]
16. Pharmacologic erection program for the treatment of male impotence.
Trapp JD
South Med J; 1987 Apr; 80(4):426-7. PubMed ID: 2436316
[TBL] [Abstract][Full Text] [Related]
17. Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence.
Montorsi F; Guazzoni G; Bergamaschi F; Zucconi M; Rigatti P; Pizzini G; Miani A; Pozza G
Acta Diabetol; 1994 Apr; 31(1):1-5. PubMed ID: 8043890
[TBL] [Abstract][Full Text] [Related]
18. How safe is the treatment of impotence with intracavernous autoinjection?
Zentgraf M; Ludwig G; Ziegler M
Eur Urol; 1989; 16(3):165-71. PubMed ID: 2663519
[TBL] [Abstract][Full Text] [Related]
19. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
Wyndaele JJ; de Meyer JM; de Sy WA; Claessens H
Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363
[TBL] [Abstract][Full Text] [Related]
20. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
von Heyden B; Donatucci CF; Kaula N; Lue TF
J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
